Windlas Biotech reported audited financial results for FY24 and Q4, with revenue of Rs. 631 Cr, EBITDA of Rs. 78 Cr, PAT of Rs. 58 Cr, EPS of Rs. 27.97, liquidity of Rs. 206 Cr, and operating cashflows of Rs. 109 Cr.
AI Assistant
Windlas Biotech Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.